Allstate downgraded by HSBC Securities with a new price target

HSBC Securities downgraded Allstate from Buy to Hold, setting a new price target of $271.00 for its shares. The company's stock has shown mixed performance following past headlines, with a median move of 1.4% in either direction.

Original reporting
Published Nov 6, 2026, 1:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 7, 2026, 10:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$ALL
Bearish
medium confidence
Mentioned
$ALL
Relevance
7/10
AlphAI data visualization · based on quantisnow.com
Decision brief

The 30-second read

$ALLBearishMed
01

Why it matters

The downgrade could trigger short-term selling pressure, affecting Allstate's stock price and possibly influencing sentiment in the insurance sector.

02

Market read

The downgrade provides a fresh catalyst for Allstate traders, offering a near-term sell signal.

03

What to watch

Potential upside from upcoming earnings or new product initiatives not covered in the downgrade.

Relevance 7/10Novelty 7/10Timing: today

Background

HSBC Securities issued a research note downgrading Allstate from Buy to Hold with a new target price of $271.

Company-level read

Ticker impact

$ALLBearishMedium confidence
Context

HSBC downgraded Allstate to Hold and set a new price target of $271.

Expected impact

downward pressure as investors price in the lower target

Evidence & confidence

Analyst downgrade with a reduced price target typically leads to short-term price weakness.

Market effects

May weigh on the property-casualty insurance sector as peers could face similar scrutiny.

Limited to U.S. insurers; broader market impact minimal.

Low global relevance beyond U.S. insurance investors.

Counterpoint

Some investors may view the downgrade as an overreaction if Allstate's fundamentals remain solid.

Key entities

  • Allstate Corporation

    U.S. property-casualty insurer whose stock is being downgraded.

  • HSBC Securities

    Research arm that issued the downgrade and new price target.

Related articles

$ALLMed

Keefe Bruyette raises Allstate stock price target on faster growth

Keefe Bruyette & Woods raised Allstate's (NYSE:ALL) price target to $241 from $232, citing faster growth expectations. They increased 2026-2028 EPS estimates but maintained an Underperform rating. Allstate's Q3 2026 earnings beat expectations, reporting $9.76 EPS and $17.3B revenue. Piper Sandler adjusted its target to $294 from $300, keeping an Overweight rating.

$TRVMed

3 Insurance Dividend Stocks Built to Keep Paying Through Tough Times

Travelers (TRV), Allstate (ALL), and Chubb (CB) are large property and casualty insurers with strong dividend histories. Travelers has raised dividends annually since 2004, yielding 1.17%. Allstate offers the highest yield at 1.59%, while Chubb has the largest market value and diverse earnings. All three maintain low payout ratios and benefit from rising investment income.

$ALLMed

What Allstate (ALL) Said on Its Q3 Earnings Call

Allstate reported Q3 earnings, noting inflation impacts on auto claims and rate adjustments in 39 locations. CEO Tom Wilson discussed reserve developments and an AI assistant planned for 2027. Net investment income rose 24%, but the portfolio saw a -2.1% return. Allstate returned $1.5B to shareholders in Q3 and repurchased 5.7% of its shares over 12 months. The company will continue quarterly reporting while focusing on long-term trends.

$ALLMed

Allstate Corp (ALL) (Q3 2026) Earnings Call Highlights: Strong Policy Growth

Allstate Corp (ALL) reported Q3 2026 earnings with a 6.5-point increase in the Property-Liability combined ratio due to higher catastrophe losses. Auto insurance premiums decreased 2.7% year-over-year. The company faces regulatory scrutiny and rising technology costs. CEO Thomas Wilson addressed investor concerns about auto loss ratios, AI investments, and regulatory challenges. Prior-year reserve releases boosted profitability but are not expected to recur at the same level.

$ALLMedAI 8/10

Allstate (NYSE:ALL) reports sales below analyst estimates in Q3 2026 earnings

Allstate (NYSE:ALL) reported Q3 2026 revenue of $17.35B, missing estimates by 1%. Adjusted EPS of $9.76 beat estimates by 40.2%. Net premiums earned grew 3.2% YoY to $15.86B, beating estimates. Book value per share grew 23.5% YoY to $120.23, missing estimates. The company highlighted growth in auto and homeowners insurance policies and expansion of its Protection Services.